Perioperative blood transfusion and radical cystectomy: Does timing of transfusion affect bladder cancer mortality?

European Urology

Volumn 66, Issue 6, 2014, Pages 1139-1147

  Abel, E Jason ^a   Linder, Brian J ^b   Bauman, Tyler M ^a   Bauer, Rebecca M ^a   Thompson, R Houston ^b   Thapa, Prabin ^b   Devon, Octavia N ^a   Tarrell, Robert F ^b   Frank, Igor ^b   Jarrard, David F ^a   Downs, Tracy M ^a   Boorjian, Stephen A ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Intraoperative blood transfusion; Outcomes; Transfusion; Urothelial carcinoma

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; RISK ASSESSMENT; CARCINOMA; CAUSE OF DEATH; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PEROPERATIVE CARE; POSTOPERATIVE CARE; SURVIVAL RATE; TIME; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS; VALIDATION STUDY;

AGED; BLOOD TRANSFUSION; CARCINOMA; CAUSE OF DEATH; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84910068640     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.051     Document Type: Article

References (32)

1. A. Amato, and M. Pescatori Perioperative blood transfusions for the recurrence of colorectal cancer Cochrane Database Syst Rev 2006 CD005033
2. A.M. Churchhouse, T.J. Mathews, O.M. McBride, and J. Dunning Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer? Interact Cardiovasc Thorac Surg 14 2012 85 90
3. S. Nagai, T. Fujii, and Y. Kodera Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas Pancreas 40 2011 3 9
4. S.C. Katz, J. Shia, and K.H. Liau Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma Ann Surg 249 2009 617 623
5. L.A. Kluth, E. Xylinas, and M. Rieken Impact of perioperative blood transfusion on the outcome of patients undergoing radical cystectomy for urothelial carcinoma of the bladder BJU Int 113 2014 393 398
6. B.J. Linder, I. Frank, and J.C. Cheville The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy Eur Urol 63 2013 839 845
7. T.M. Morgan, D.A. Barocas, and S.S. Chang The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer Urol Oncol 31 2013 871 877
8. E.C. Vamvakas, and M.A. Blajchman Transfusion-related immunomodulation (TRIM): an update Blood Rev 21 2007 327 348
9. L.A. Colvin, M.T. Fallon, and D.J. Buggy Cancer biology, analgesics, and anaesthetics: is there a link? Br J Anaesth 109 2012 140 143
10. M. Pesta, J. Fichtl, V. Kulda, O. Topolcan, and V. Treska Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer Anticancer Res 33 2013 2239 2243
11. S. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC Cancer Staging Manual ed. 7. 2010 Springer New York, NY
12. T. Ojima, M. Iwahashi, and M. Nakamori Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy J Gastrointest Surg 13 2009 1821 1830
13. L.S. Jensen, A.J. Andersen, and P.M. Christiansen Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery Br J Surg 79 1992 513 516
14. E.C. Vamvakas Possible mechanisms of allogeneic blood transfusion-associated postoperative infection Transfus Med Rev 16 2002 144 160
15. J.P. Cata, H. Wang, V. Gottumukkala, J. Reuben, and D.I. Sessler Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions Br J Anaesth 110 2013 690 701
16. M.M. Heiss, W. Mempel, and C. Delanoff Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery J Clin Oncol 12 1994 1859 1867
17. J.G. Houbiers, A. Brand, and L.M. van de Watering Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer Lancet 344 1994 573 578
18. F.E. Lennon, J. Moss, and P.A. Singleton The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology 116 2012 940 945
19. L.L. Benzonana, N.J. Perry, and H.R. Watts Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro Anesthesiology 119 2013 593 605
20. A. Shander, A. Fink, and M. Javidroozi Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes Transfus Med Rev 25 2011 232-246.e53
21. S.M. Frank, W.J. Savage, and J.A. Rothschild Variability in blood and blood component utilization as assessed by an anesthesia information management system Anesthesiology 117 2012 99 106
22. V.A. Ferraris, E.Q. Ballert, and A. Mahan The relationship between intraoperative blood transfusion and postoperative systemic inflammatory response syndrome Am J Surg 205 2013 457 465
23. J.L. Carson, B.J. Grossman, and S. Kleinman Red blood cell transfusion: a clinical practice guideline from the AABB∗ Ann Intern Med 157 2012 49 58
24. P.C. Hebert, G. Wells, and M.A. Blajchman A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group N Engl J Med 340 1999 409 417
25. L.M. Napolitano, S. Kurek, and F.A. Luchette Clinical practice guideline: red blood cell transfusion in adult trauma and critical care Crit Care Med 37 2009 3124 3157
26. D.A. Henry, P.A. Carless, and A.J. Moxey Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2011 CD001886
27. E.S. Lundin, T. Johansson, and H. Zachrisson Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study Acta Obstet Gynecol Scand 93 2014 335 344
28. A. Crescenti, G. Borghi, and E. Bignami Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial BMJ 343 2011 d5701
29. Tranexamic Acid During Cystectomy Trial (TACT) pilot study [identifier NCT01869413 ]. ClinicalTrials.gov Web site. http://clinicaltrials.gov/show/NCT01869413. Updated February 7, 2014.
30. P.Y. Wuethrich, F.C. Burkhard, G.N. Thalmann, S. Stueber, and U.E. Studer Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial Anesthesiology 120 2014 365 377
31. J. Nix, A. Smith, and R. Kurpad Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results Eur Urol 57 2010 196 201
32. Open vs robotic-assisted radical cystectomy: a randomized trial [identifier NCT01157676 ]. ClinicalTrials.gov Web site. http://clinicaltrials.gov/show/NCT01157676. Updated February 8, 2014.